Iridex Announces Strategic Review to Unlock Shareholder Value
August 29, 2023 16:05 ET
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX) announced today that its Board of Directors is undertaking, in consultation with its financial and legal...
Iridex Reports Second Quarter 2023 Financial Results
August 10, 2023 16:05 ET
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal...
Iridex to Report Second Quarter Financial Results on August 10, 2023
July 27, 2023 16:05 ET
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., July 27, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal...
Iridex Reports First Quarter 2023 Financial Results
May 11, 2023 16:05 ET
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., May 11, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal...
Iridex to Report First Quarter Financial Results on May 11, 2023
April 27, 2023 16:05 ET
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., April 27, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and...
Iridex Reports Fourth Quarter and Full Year 2022 Financial Results
March 09, 2023 16:05 ET
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., March 09, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and...
Iridex to Present at the 35th Annual Roth Conference
March 07, 2023 16:05 ET
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., March 07, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and...
Iridex Introduces New Research and Showcases Five Events at the AGS Meeting
March 02, 2023 09:00 ET
|
IRIDEX Corporation
Five Events at Booth #5 Discover the latest surgical techniques and outcomes published by the International MicroPulse TLT Consensus Panel.Watch Dr. Syril Dorairaj’s e-poster on prospective...
Iridex to Report Fourth Quarter and Full Year 2022 Financial Results on March 9, 2023
February 23, 2023 16:05 ET
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal...
Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2022
January 10, 2023 16:05 ET
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., Jan. 10, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal...